Valuation: BOIRON

Market Cap 311M 348M 287M 260M 487M 33.04B 495M 3.45B 1.37B 17.31B 1.31B 1.28B 54.57B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 263M 294M 243M 220M 412M 27.95B 419M 2.92B 1.16B 14.64B 1.1B 1.08B 46.17B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
12.84%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.56%
1 week-3.76%
Current month-10.50%
1 month-9.60%
3 months-34.43%
6 months-30.35%
Current year-40.92%
1 week 17.45
Extreme 17.45
18.6
1 month 16.9
Extreme 16.9
20.9
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
43.96
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%-3.76%-34.19%-55.25% 348M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.66%+1.58%+29.80%+58.28% 400.47B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.12%

Financials

2024 2025
Net sales 488M 546M 450M 408M 764M 51.83B 776M 5.42B 2.15B 27.16B 2.05B 2.01B 85.61B 501M 561M 463M 420M 785M 53.27B 798M 5.57B 2.21B 27.91B 2.11B 2.06B 87.99B
Net income 11.34M 12.69M 10.47M 9.49M 17.75M 1.21B 18.05M 126M 49.89M 631M 47.64M 46.63M 1.99B 32.64M 36.55M 30.16M 27.33M 51.13M 3.47B 51.97M 363M 144M 1.82B 137M 134M 5.73B
Net Debt -49.74M -55.7M -45.95M -41.64M -77.9M -5.29B -79.19M -553M -219M -2.77B -209M -205M -8.73B -47.86M -53.59M -44.21M -40.06M -74.95M -5.09B -76.19M -532M -211M -2.67B -201M -197M -8.4B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
26-10-23 €17.90 -0.56% 7,191
26-10-22 €18.00 +0.28% 11,879
26-10-21 €17.95 -0.28% 10,143
26-10-20 €18.00 -0.83% 3,156
26-10-19 €18.15 -2.42% 3,661

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON